BEAM:NASDAQ
Beam Therapeutics Inc
$29.66
arrow_upward
+0.68%(+0.20) 1D
$30.37
arrow_upward
+2.39% (+0.71)bedtimeAfter hours
Closed: Sep 4, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BEAM...
Open
$28.91
High
$29.97
Low
$28.91
Mkt. cap
3.06B
Avg. vol.
1.61M
Volume
1.18M
52-wk high
$38.26
52-wk low
$18.72
EPS
-$0.81
Beta
2.22
Shares outstanding
103.29M
No. of employees
540
Open
$28.91
High
$29.97
Low
$28.91
Mkt. cap
3.06B
Avg. vol.
1.61M
Volume
1.18M
52-wk high
$38.26
52-wk low
$18.72
EPS
-$0.81
Beta
2.22
Shares outstanding
103.29M
No. of employees
540
News stories
From web sources and news partners
https://www.dars.gov.et/
·
1 week ago
BEAM Q2 2026 Earnings: Wider-than-Expected Loss Drives 3.09% Share Decline - Return On Capital
Profile
Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks. Wikipedia
About Beam Therapeutics Inc